IDYA Latest Headlines

IDEAYA Biosciences (IDYA) Receives a Hold from Goldman Sachs

at www.tipranks.com (Tue, 14-Apr 7:28 AM)

Wells Fargo Remains a Buy on IDEAYA Biosciences (IDYA)

at www.tipranks.com (Tue, 14-Apr 7:22 AM)

Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON) and IDEAYA Biosciences (IDYA)

at www.tipranks.com (Tue, 14-Apr 7:10 AM)

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), IDEAYA Biosciences (IDYA) and Ligand Pharma (LGND)

at www.tipranks.com (Tue, 14-Apr 7:01 AM)

IDEAYA Biosciences Sets April 13 for Major Metastatic Uveal Melanoma Trial Update: What to Watch

Market Chameleon (Mon, 13-Apr 10:46 AM)

IDEAYA's Darovasertib Combo Shows Significant Advantage in Phase 2/3 Uveal Melanoma Trial

Market Chameleon (Mon, 13-Apr 8:25 AM)

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Royalty Pharma (RPRX) and IDEAYA Biosciences (IDYA)

at www.tipranks.com (Mon, 13-Apr 12:41 PM)

Top Quant rated communications equipment stocks as Nokia Oyj surges

at seekingalpha.com (Mon, 13-Apr 12:19 PM)

Biggest stock movers Monday: REPL, GS, LEG and more

at seekingalpha.com (Mon, 13-Apr 10:00 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: IDEAYA Biosciences (IDYA), BioNTech SE (BNTX) and Stryker (SYK)

at www.tipranks.com (Mon, 13-Apr 8:10 AM)

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and Certara (CERT)

at www.tipranks.com (Mon, 13-Apr 5:10 AM)

IDEAYA Pivots to Global Phase 1 Combo Study: Early Signs Point to Synergy in Tumor Treatment

Market Chameleon (Mon, 30-Mar 7:31 AM)